Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: TXRH stock price vs CNC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CNC's multiple
Needs CNC P/E.
Implied fair value · at TXRH's multiple
Needs EPS (TTM) is negative, TXRH P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TXRH FY 2025 (ended Dec 30, 2025) · CNC FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Texas Roadhouse, Inc. · implied price per share
Bear
$25.76
Base
$30.31
Bull
$34.85
CENTENE CORPORATION · implied price per share
Bear
-$229.28
Base
-$269.74
Bull
-$310.20
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.87x
Net debt / EBITDA
Leverage against operating earnings
-0.27x
0.72x
Cash and equivalents
Liquid reserves on the balance sheet
$134.71M
$20.32B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$2.08M
$17.40B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe TXRH can sustain its current premium valuation despite a 2.3x P/S multiple and only a 5/9 Piotroski F-Score, then hold; otherwise, the data favor reducing exposure because CNC-implied and DCF ranges are far below the current price.
The valuation gap is extreme: TXRH trades at $208.50 versus an implied price of $14.91 on CNC P/S comparison, implying -92.8% downside. That gap is driven by TXRH’s much richer sales multiple versus CNC, even though TXRH is the higher-quality business on profitability and leverage.
Supporting Metrics
